Nutex Health (NUTX) Equity Average (2011 - 2026)

Nutex Health (NUTX) has 15 years of Equity Average data on file, last reported at $432.7 million in Q1 2026.

• Quarterly Equity Average rose 95.02% year-over-year to $432.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $432.7 million (up 95.02% YoY) and the FY2025 annual result came in at $306.0 million, up 128.66% from the prior year.
• Equity Average held at $432.7 million in Q1 2026 per NUTX's latest filing, from $430.7 million in the prior quarter.
• The five-year high for Equity Average was $432.7 million in Q1 2026, with the low at $79.6 million in Q1 2024.
• Average Equity Average over 5 years is $211.7 million, with a median of $134.2 million recorded in 2024.
• Year-over-year, Equity Average sank 70.71% in 2023 and jumped 378.93% in 2025.
• Nutex Health's Equity Average stood at $126.4 million in 2022, then declined by 27.23% to $92.0 million in 2023, then surged by 45.81% to $134.2 million in 2024, then soared by 221.07% to $430.7 million in 2025, then advanced by 0.47% to $432.7 million in 2026.
• Business Quant data shows NUTX's Equity Average at $432.7 million in Q1 2026, $430.7 million in Q4 2025, and $387.5 million in Q3 2025.